Aerssens; Jeroen

Patent Applications and Registrations

Patent applications and USPTO patent grants for Aerssens; Jeroen.The latest application filed is for "predictive value of il28b gene polymorphism combined with pretreatment serum ip-10 quantification for response to peginterferon and ribavirin is enhanced in comparison with any of these biomarkers alone".

Company Profile

0.3.16

Aerssens; Jeroen - Wilsele N/A BE
Aerssens; Jeroen - Nieuwrode Holsbeek
Aerssens; Jeroen - Nieuwrode BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Data mining of SNP databases for the selection of intragenic SNPs Grant 8,725,418 - Aerts , et al. May 13, 2	2014-05-13
Predictive Value of IL28B Gene Polymorphism Combined with Pretreatment Serum IP-10 Quantification for Response to Peginterferon and Ribavirin Is Enhanced in Comparison with any of these Biomarkers alone App 20120252695 - Aerssens; Jeroen ; et al.	2012-10-04
CDK5 genetic markers associated with galantamine response App 20080166723 - Aerssens; Jeroen ; et al.	2008-07-10
CDK5 genetic markers associated with galantamine response Grant 7,250,258 - Aerssens , et al. July 31, 2	2007-07-31
NTRK1 genetic markers associated with progression of Alzheimer's disease App 20060166219 - Aerssens; Jeroen ; et al.	2006-07-27
LDLR genetic markers associated with age of onset of Alzheimer's Disease App 20060154265 - Aerssens; Jeroen ; et al.	2006-07-13
APOE genetic markers associated with age of onset of Alzheimer's disease App 20050277129 - Aerssens, Jeroen ; et al.	2005-12-15
LRPAP1 genetic markers associated with galantamine App 20050260613 - Aerssens, Jeroen ; et al.	2005-11-24
CDK5 genetic markers associated with galantamine response App 20050255494 - Aerssens, Jeroen ; et al.	2005-11-17
NTRK1 genetic markers associated with age of onset of Alzheimer's Disease App 20050255488 - Aerssens, Jeroen ; et al.	2005-11-17
APOC1 genetic markers associated with age of onset of Alzheimer's Disease App 20050255498 - Aerssens, Jeroen ; et al.	2005-11-17
SLC5A7 genetic markers associated with age of onset of Alzheimer's disease App 20050255495 - Aerssens, Jeroen ; et al.	2005-11-17
CHRNA9 genetic markers associated with progression of Alzheimer's disease App 20050255492 - Aerssens, Jeroen ; et al.	2005-11-17
EPHX2 Genetic markers associated with galantamine App 20050250118 - Aerssens, Jeroen ; et al.	2005-11-10
NTRK2 genetic markers associated with progression of Alzheimer's disease App 20050250121 - Aerssens, Jeroen ; et al.	2005-11-10
APOA4 genetic markers associated with progression of Alzheimer's disease App 20050250122 - Aerssens, Jeroen ; et al.	2005-11-10
CHRNA2 genetic markers associated with galantamine response App 20050048543 - Aerssens, Jeroen ; et al.	2005-03-03
Data mining of SNP databases for the selection of intragenic SNPs App 20030190649 - Aerts, Jan ; et al.	2003-10-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.